wockhardt pharma

#1
Wockhardt Pharma

Target 570

Period Longterm

Wockhardt Pharma The Facts!!!!!!!!!!

Fundamental Analysis


Wockhardt Acquires The Negma Pharma In Europe

Negma Pharma Is A Patent Based Drug Company. It Has 2 Patent

1 Is Hypertension And 2 Is Broncaitist

So That It Gives Good Advantage To Wockhardt In European Market

On The Other Hand Negma Pharma Has A Record Break Selling Of 150 Million Last Year

The Acquistion Cost Of Wockhardt For This Company Is 275 Million

The Other Thing Is Euro Is Increases Against Rupee So That It Will Give Benifits To Wockhardt

The 2nd Acquistion Of Wockhardt Is Pinewood Pharma

So In This Way Wockhardt Pharma Will Be A Good Stock To Buy At The Market Price Is Around 390 To 410

The Company Also Performing Very Well In The Domestic Market
And Its Special Economic Zone Project Of Wockhardt Suncity Will Also Help To Generate The Profit

The Sez Will Developed In Auragabad In Maharastra

Where Company Already Have Their Manufacturing Plant

This Is All About The Fundamental Analysis Of The Wockhardt

Prepared By
Nishith
 
#2
buy LNG petronet

LNG petronet will increase with market trend

the price is around 64 to 65 and

company got a 10 years benifits not to paid custom duty in lng exploration

company also annouces to develop a dahej cargo port with joint venture of adani group and introduce special purpose vechile for financing this cargo port

the stock is recommed to buy by analyst also
 

Similar threads